Medtronic
ProfileJobs (2.29 k)

Medtronic

Suggest Edit
    • HealthcareManufacturing & Industrialimagingmedical devicesmedtechsurgical solutions
    Medtronic manufactures and sells device-based medical therapies. Its products include pacemakers, insertable cardiac monitors, implantable defibrillators, leads and delivery systems, ablation products, electrophysiology catheters, coronary and peripheral stents and related delivery systems, therapies for uncontrolled hypertension, endovascular stent graft systems, heart valve replacement technologies, and cardiac tissue ablation systems. The Company also manufactures image-guided surgery and intra-operative imaging systems.
    Revenue(FY, 2018)
    $30 B
    Market capitalization(2018-11-09)
    $127.7 B
    Patients(FY, 2016)
    65 M

    Employee Rating

    3.7More
    TypePublic
    HQMinneapolis, US
    Founded1949
    Size (employees)86,000 (est)
    Websitemedtronic.com
    Medtronic was founded in 1949 and is headquartered in Minneapolis, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at Medtronic

    Omar Ishrak

    Omar Ishrak

    CEO, Chairman
    Karen Parkhill

    Karen Parkhill

    EVP, CFO
    Richard Kuntz

    Richard Kuntz

    SVP, Chief Medical and Scientific Officer
    Carol Surface

    Carol Surface

    SVP and Chief Human Resources Officer
    Show more

    Medtronic Office Locations

    Medtronic has offices in Astana, Singapore, Dubai, Century City Cape Town and in 83 other locations
    Minneapolis, US (HQ)
    710 Medtronic Parkway
    Doral, US
    450 9850 NW 41st St
    Doral, US
    9850 NW 41st Street, Suite 450
    Miami, US
    Doral Corporate Centre II, 3750 NW 87th Avenue, Suite 700
    Plymouth, US
    3800 Annapolis Ln N #175
    Portsmouth, US
    180 International Dr
    Show all (95)
    Report incorrect company information

    Medtronic Financials and Metrics

    Medtronic Revenue

    Embed Graph
    Medtronic's revenue was reported to be $29.95 b in FY, 2018 which is a 0.8% increase from the previous period.
    USD

    Revenue (Q1, 2019)

    		7.4b

    Gross profit (Q1, 2019)

    		5.2b

    Gross profit margin (Q1, 2019), %

    		70.2%

    Net income (Q1, 2019)

    		1.1b

    EBIT (Q1, 2019)

    		1.2b

    Market capitalization (9-Nov-2018)

    		127.7b

    Closing stock price (9-Nov-2018)

    		94.4

    Cash (27-Jul-2018)

    		4.4b

    EV

    		147.0b
    Medtronic's current market capitalization is $127.7 b.
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Revenue

    		17.0b20.3b28.8b29.7b30.0b

    Revenue growth, %

    		19%42%3%1%

    Cost of goods sold

    		4.3b6.3b9.1b9.3b9.1b

    Gross profit

    		12.7b14.0b19.7b20.4b20.9b
    Quarterly
    USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

    Revenue

    		7.3b7.1b6.9b7.2b7.3b7.3b7.4b7.1b21.8b7.4b

    Cost of goods sold

    		2.5b2.2b2.1b2.3b2.3b2.3b2.3b2.1b6.7b2.2b

    Gross profit

    		4.8b4.9b4.8b4.9b5.0b5.0b5.0b4.9b15.1b5.2b

    Gross profit Margin, %

    		66%69%69%68%68%69%68%70%69%70%
    show all
    Annual
    USDY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Cash

    		13.2m4.8b186.4m5.0b3.7b

    Accounts Receivable

    		17.1m5.6b6.0b

    Inventories

    		1.7b3.5b3.5b3.3b3.6b

    Current Assets

    		21.2b30.8b23.6b24.9b23.0b
    Quarterly
    USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

    Cash

    		46.0k3.0b2.4b2.7b3.1b3.0b2.8b4.7b5.5b6.4b4.4b

    Accounts Receivable

    		(68.0m)

    Inventories

    		3.4b3.5b3.5b3.6b3.7b3.7b3.5b3.8b3.7b

    Current Assets

    		46.0k29.1b28.7b27.6b23.5b22.5b22.4b24.8b25.2b26.6b22.5b
    show all
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Net Income

    		3.1b2.7b3.5b4.0b3.1b

    Depreciation and Amortization

    		349.0m1.3b2.8b2.0b2.6b

    Inventories

    		(39.0m)(282.0m)(186.0m)(227.0m)(192.0m)

    Accounts Payable

    Quarterly
    USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

    Net Income

    		(37.1m)820.0m1.3b2.4b929.0m2.0b2.9b1.0b3.0b1.6b1.1b

    Depreciation and Amortization

    		701.0m1.4b2.1b737.0m1.5b2.2b636.0m1.3b2.0b666.0m

    Inventories

    		(207.0m)(326.0m)(388.0m)(101.0m)(187.0m)(261.0m)(273.0m)(318.0m)(180.0m)

    Accounts Payable

    		1.3b1.4b1.4b(307.0m)13.0m85.0m
    show all
    USDY, 2018

    EV/EBIT

    		118.9 x

    EV/CFO

    		86.4 x

    Debt/Equity

    		0.5 x

    Debt/Assets

    		0.3 x

    Financial Leverage

    		1.8 x
    Show all financial metrics

    Medtronic Operating Metrics

    Medtronic's Patients was reported to be 65 m in FY, 2016.
    FY, 2014FY, 2015FY, 2016

    Countries

    		160 160

    Patents Issued

    		27 k53 k45 k

    Patients

    		65 m
    Show all operating metrics

    Medtronic Acquisitions / Subsidiaries

    Acquired CompanyDateDeal Size
    Mazor RoboticsSeptember 21, 2018$1.64 b
    Visionsense LtdApril 11, 2018$75 m

    Medtronic Revenue Breakdown

    Embed Graph

    Medtronic revenue breakdown by business segment: 7.1% from Diabetes Group, 25.9% from Restorative Therapies Group, 37.9% from Cardiac and Vascular Group and 29.1% from Minimally Invasive Therapies Group

    Medtronic revenue breakdown by geographic segment: 46.7% from Rest of World, 53.0% from United States and 0.3% from Other

    Human Capital Metrics

    Source: www.medtronic.com, www.medtronic.com
    Medtronic's employees are reported to be approximately 49% female and 51% male.
    Embed Graph
    Show all human capital metrics
    Report incorrect company information

    Competitors

    Olympus Corporation
    Manufacturing & Industrial - Public
    Nikkiso
    Manufacturing & Industrial - Public
    Boston Scientific
    Healthcare - Public
    Stryker
    Healthcare - Public
    St. Jude Medical
    Healthcare - Subsidiary
    Zimmer Biomet
    Healthcare - Public
    Compare competitors

    Medtronic Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Medtronic News and Updates

    November 14, 2018

    Cardiac Rhythm Management Market Size, Trends, Segments, Analysis with Key Player List: Medtronic Plc, St. Jude Medical Inc, Boston Scientific Corporation, Abbott Laboratories, Biotronik - 2025

    Cardiac rhythm management market is the established segment of cardiology devices market, used majorly in the treatment of patients suffering from congestive heart failure (CHF) and atrial fibrillation (AF). Posted via Industry Today. Follow us on Twitter @IndustryToday
    November 13, 2018

    Global Cranial Fixation and Stabilization Devices Market, 2018-2025 with Stryker, Medtronic, Ostomed, Johnson & Johnson, Integra LifeSciences, KLS Martin, and Braun Dominating

    DUBLIN, Nov. 13, 2018 /PRNewswire/ -- The "Cranial Fixation and Stabilization Devices Market Size, Share & Trends Analysis Report By Product (Fixation Devices, Stabilization Devices), By End Use (Hospitals, ASCs), And Segment Forecasts, 2018 - 2025" report has been added to...
    November 12, 2018

    Liver Biopsy Market Will Touch a New Level in Upcoming Year – Key Players Involved in the Research Like Boston Scientific Corporation, INRAD Inc., Argon Medical Devices Inc., Medtronic

    Liver Biopsy Market from Qurate’s Repository provides detailed information, in depth analysis and forecast which is developed by team of experts and professionals. Posted via Industry Today. Follow us on Twitter @IndustryToday
    November 09, 2018

    Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2019

    DUBLIN - November 9, 2018 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the second quarter of fiscal year 2019 on Tuesday, November 20, 2018. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com.…
    November 08, 2018

    Medtronic Delivers Significant Progress on Global Corporate Citizenship Efforts

    2018 Integrated Performance Report Shows Improvement on Environmental Stewardship and Diversity Aspirational Goals
    November 08, 2018

    Medtronic Begins Renal Denervation Study for High Blood Pressure Patients Prescribed Anti-Hypertensive Medication

    FDA-Approved Study Furthers Medtronic Commitment to Generate Meaningful Clinical Evidence for Use of Renal Denervation to Treat Uncontrolled Hypertension
    Show more
    Report incorrect company information

    Medtronic Company Life and Culture

    Report incorrect company information
    Download PDF

     Medtronic Frequently Asked Questions

    wdxefcqufszuzezftuxetqsqxt

    • When was Medtronic founded?

      Medtronic was founded in 1949.

    • Who are Medtronic key executives?

      Medtronic's key executives are Omar Ishrak, Karen Parkhill and Richard Kuntz.

    • How many employees does Medtronic have?

      Medtronic has 86,000 employees.

    • What is Medtronic revenue?

      Latest Medtronic annual revenue is $30 b.

    • What is Medtronic revenue per employee?

      Latest Medtronic revenue per employee is $348.3 k.

    • Who are Medtronic competitors?

      Competitors of Medtronic include Olympus Corporation, Nikkiso and Boston Scientific.

    • Where is Medtronic headquarters?

      Medtronic headquarters is located at 710 Medtronic Parkway, Minneapolis.

    • Where are Medtronic offices?

      Medtronic has offices in Astana, Singapore, Dubai, Century City Cape Town and in 83 other locations.

    • How many offices does Medtronic have?

      Medtronic has 95 offices.